AChE/BChE-IN-31

• Description :

  AChE/BChE-IN-31 (Compound 3c) is a cholinesterase inhibitor. AChE/BChE-IN-31 exhibits certain inhibitory activity against hAChE and eqBChE. AChE/BChE-IN-31 also possesses antioxidant properties with an IC50 value of 105.04 μM against DPPH. AChE/BChE-IN-31 can be used in the research of diseases such as Alzheimer’s disease[1].

• UNSPSC :

  12352005

• Hazard Statement :

  H401-H411

• Target :

  Cholinesterase (ChE) ; Drug Intermediate

• Related Pathways :

  Neuronal Signaling; Others

• Field of Research :

  Inflammation/Immunology; Neurological Disease

• Smiles :

  O=C(C=CC1=CC=C(OC)C=C1)C2=CC=C(O)C=C2

• Molecular Formula :

  C16H14O3

• Molecular Weight :

  254.29

• Precautions :

  P273-P391-P501

• References & Citations :

  [1]Kumar H, et al. Design, Synthesis, and biological evaluation of pyrazolo-benzothiazole derivatives as a potential therapeutic agent for the treatment of Alzheimer’s disease. Medicinal Chemistry Research, 2022, 31 (11) : 1931-1947.

• Shipping Conditions :

  Room temperature

• Scientific Category :

  Reference compound2

• Clinical Information :

  No Development Reported

• CAS Number :

  [6338-81-4]